Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The relevance of false positive acid phosphatase reactions indicative of the presence of seminal fluid from oral and vaginal samples.

Science & justice : journal of the Forensic Science Society·2023
Same author

Mr. Hammick's Case of Gun-Shot Wound.

The Medical and physical journal·2018
Same author

Treatment of Puerperal Septicæmia.

Edinburgh medical journal·2018
Same author

Early Warning Scores do not accurately predict mortality in sepsis: A meta-analysis and systematic review of the literature.

The Journal of infection·2018
Same author

Editorial: are earlier referrals to transplant centres responsible for improved outcomes in patients with acute liver failure? Authors' reply.

Alimentary pharmacology & therapeutics·2017
Same author

Acute liver failure in Scotland: changes in aetiology and outcomes over time (the Scottish Look-Back Study).

Alimentary pharmacology & therapeutics·2017

Related Experiment Video

Updated: Jun 5, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Molecular atherectomy for restenosis.

W Casscells1, D A Lappi, A Baird

  • 1Texas Heart Institute and University of Texas Medical School, Houston, TX 77225-0345 USA.

Trends in Cardiovascular Medicine
|January 20, 2011
PubMed
Summary

Basic fibroblast growth factor (FGF) conjugates can selectively kill activated smooth muscle cells. This targeted approach inhibits cell proliferation and neointimal growth in vivo, offering potential therapeutic strategies.

More Related Videos

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application
06:53

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application

Published on: July 9, 2020

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
13:48

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

Published on: April 21, 2023

Related Experiment Videos

Last Updated: Jun 5, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application
06:53

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application

Published on: July 9, 2020

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
13:48

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

Published on: April 21, 2023

Area of Science:

  • Vascular biology
  • Cell signaling
  • Drug delivery

Background:

  • Basic (b) and acidic (a) fibroblast growth factor (FGF) receptors are upregulated in activated smooth muscle cells.
  • Activated smooth muscle cells proliferate in response to bFGF.
  • Quiescent cells with low FGF receptor expression are unaffected.

Purpose of the Study:

  • To investigate the selective killing of activated smooth muscle cells using a bFGF-saporin conjugate.
  • To evaluate the in vivo efficacy of bFGF-saporin in inhibiting smooth muscle cell proliferation and neointimal accumulation after vascular injury.
  • To explore targeted delivery strategies for therapeutic agents to activated smooth muscle cells.

Main Methods:

  • Conjugation of bFGF with the ribosome-inactivating enzyme saporin.
  • In vitro assessment of cell killing in activated versus quiescent smooth muscle cells.
  • In vivo studies using a rat carotid artery balloon injury model to evaluate bFGF-saporin efficacy.
  • Discussion of antibody-mediated targeted delivery strategies.

Main Results:

  • The bFGF-saporin conjugate selectively killed activated smooth muscle cells expressing high levels of FGF receptors.
  • Quiescent smooth muscle cells and other cells with low FGF receptor expression were not killed.
  • In vivo, bFGF-saporin transiently inhibited smooth muscle cell proliferation and neointimal accumulation post-injury.
  • Antibodies targeting FGF receptors could enhance selectivity for drug delivery.

Conclusions:

  • Targeting upregulated FGF receptors on activated smooth muscle cells with bFGF-saporin is a viable strategy for selective cell ablation.
  • This approach demonstrates potential for managing vascular proliferative diseases.
  • Further development of targeted delivery systems, such as antibody conjugates, could improve therapeutic outcomes.